Advanced in Neurofibromatosis

Dr. Fawn A. Leigh

Neurology | Pediatrics
4800 Sand Point Way Ne, 
Seattle, WA 
Accepting New Patients
Advanced in Neurofibromatosis
4800 Sand Point Way Ne, 
Seattle, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Fawn Leigh is a Neurologist and a Pediatrics provider in Seattle, Washington. Dr. Leigh is rated as an Advanced provider by MediFind in the treatment of Neurofibromatosis. Her top areas of expertise are Legius Syndrome, Neurofibromatosis, RASopathies, and Primary Lateral Sclerosis. Dr. Leigh is currently accepting new patients.

Her clinical research consists of co-authoring 5 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Neurofibromatosis.

Specialties
Neurology
Pediatrics
Licenses
Pediatrics in NC
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
PacificSource
  • PPO

Locations

4800 Sand Point Way Ne, Seattle, WA 98105

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
Enrollment Status: Completed
Publish Date: January 18, 2024
Intervention Type: Drug
Study Drug: Ataluren
Study Phase: Phase 3
A Phase IIb Randomized, Double-blind, Parallel Group, Placebo- and Active-controlled Study With Double-Blind Extension to Assess the Efficacy and Safety of Vamorolone in Ambulant Boys With Duchenne Muscular Dystrophy (DMD)
A Phase IIb Randomized, Double-blind, Parallel Group, Placebo- and Active-controlled Study With Double-Blind Extension to Assess the Efficacy and Safety of Vamorolone in Ambulant Boys With Duchenne Muscular Dystrophy (DMD)
Enrollment Status: Completed
Publish Date: March 09, 2023
Intervention Type: Drug, Other
Study Drugs: Vamorolone, Prednisone
Study Phase: Phase 2
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: January 25, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

5 Total Publications

Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis.
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis.
Journal: JAMA neurology
Published: August 30, 2021
Similar Doctors
Distinguished in Neurofibromatosis
Dr. Jerome Graber
Neurology
Distinguished in Neurofibromatosis
Dr. Jerome Graber
Neurology

The Association Of University Physicians

1959 Ne Pacific St, 
Seattle, WA 
 (1.4 miles away)
206-598-4333
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jerome Graber is a Neurologist in Seattle, Washington. Dr. Graber is rated as a Distinguished provider by MediFind in the treatment of Neurofibromatosis. His top areas of expertise are Glioma, Brain Tumor, Metastatic Brain Tumor, and Astrocytoma.

Distinguished in Neurofibromatosis
Dr. Aimee Sato
Pediatric Neurology | Neurology
Distinguished in Neurofibromatosis
Dr. Aimee Sato
Pediatric Neurology | Neurology
4800 Sand Point Way Ne, 
Seattle, WA 
 (0.1 miles away)
206-987-2078
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Aimee Sato is a Pediatric Neurologist and a Neurologist in Seattle, Washington. Dr. Sato is rated as an Advanced provider by MediFind in the treatment of Neurofibromatosis. Her top areas of expertise are Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Optic Glioma, and Pediatric Low-Grade Glioma (pLGG).

Advanced in Neurofibromatosis
Dr. Lynne Taylor
Neurology | Hematology | Oncology
Advanced in Neurofibromatosis
Dr. Lynne Taylor
Neurology | Hematology | Oncology

The Association Of University Physicians

1959 Ne Pacific St, 
Seattle, WA 
 (1.4 miles away)
206-598-4333
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Lynne Taylor is a Neurologist and a Hematologist in Seattle, Washington. Dr. Taylor has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in the treatment of Neurofibromatosis. Her top areas of expertise are Brain Tumor, Glioblastoma, Astrocytoma, and Glioma.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Leigh's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile